Verzenio

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0002-5337
  • Package NDC 0002-5337-54
  • Package NDC 0002-5337-62
  • Application number NDA208716
  • SPL ID 02db1b7f-c6fc-4f7c-96d3-8ab9b8b97068
  • SPL set ID be4bc0de-0fdc-4d46-8d25-be43c79e6a06
  • UNII 60UAB198HK
  • RxCUI 1946830
  • RxCUI 1946836
  • RxCUI 1946838
  • RxCUI 1946840
  • RxCUI 1946842
  • RxCUI 1946844
  • RxCUI 1946846
  • RxCUI 1946848

What the source publishes

Labeler
Eli Lilly and Company
Active ingredients
abemaciclib
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0002-5337_02db1b7f-c6fc-4f7c-96d3-8ab9b8b97068
{
  "name": "Verzenio",
  "splId": "02db1b7f-c6fc-4f7c-96d3-8ab9b8b97068",
  "labels": [
    {
      "setId": "be4bc0de-0fdc-4d46-8d25-be43c79e6a06",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be4bc0de-0fdc-4d46-8d25-be43c79e6a06",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be4bc0de-0fdc-4d46-8d25-be43c79e6a06"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Eli Lilly and Company",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BLISTER PACK in 1 CARTON (0002-5337-54)  / 14 TABLET in 1 BLISTER PACK",
      "package_ndc": "0002-5337-54",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171006"
    },
    {
      "sample": true,
      "description": "2 BLISTER PACK in 1 CARTON (0002-5337-62)  / 14 TABLET in 1 BLISTER PACK",
      "package_ndc": "0002-5337-62",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250215"
    }
  ],
  "productId": "0002-5337_02db1b7f-c6fc-4f7c-96d3-8ab9b8b97068",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "0002-5337",
  "deaSchedule": null,
  "genericName": "abemaciclib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ABEMACICLIB",
      "strength": "150 mg/1"
    }
  ],
  "applicationNumber": "NDA208716",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20170928",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175605",
      "N0000175082"
    ],
    "unii": [
      "60UAB198HK"
    ],
    "rxcui": [
      "1946830",
      "1946836",
      "1946838",
      "1946840",
      "1946842",
      "1946844",
      "1946846",
      "1946848"
    ],
    "spl_set_id": [
      "be4bc0de-0fdc-4d46-8d25-be43c79e6a06"
    ],
    "pharm_class_epc": [
      "Kinase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Kinase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Eli Lilly and Company"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0002-5337_02db1b7f-c6fc-4f7c-96d3-8ab9b8b97068"